Mutant CuZn superoxide dismutase in motor neuron disease

Journal of Inherited Metabolic Disease

Volumn 21, Issue 5, 1998, Pages 587-597

  Gurney, M E ^a   Liu, R ^b,d   Althaus, J S ^a   Hall, E D ^a   Becker, D A ^c  

^a PFIZER INC   (United States)

^b WESTERN MICHIGAN UNIVERSITY   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; GABAPENTIN; NEUROPROTECTIVE AGENT; OXYGEN RADICAL; RILUZOLE;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN CORTEX; BRAIN STEM; CHELATION THERAPY; CONFERENCE PAPER; DISEASE DURATION; GENE MUTATION; HUMAN; MOTONEURON; MOTOR NEURON DISEASE; SPINAL CORD; SURVIVAL TIME;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; MICE; MICE, TRANSGENIC; MOTOR NEURON DISEASE; SUPEROXIDE DISMUTASE;

EID: 0031818024     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005475206997     Document Type: Conference Paper

References (42)

1. Andersen PM, Nilsson P, Ala-Hurula V, et al (1995) Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genetics 10: 61-66.
2. Becker DA (1996) Highly sensitive colorimetric detection and facile isolation of diamagnetic free radical adducts of novel chromotropic nitrone spin trapping agents readily derived from guaiazulene. J Am Chem Soc 118: 905-906.
3. Borchelt DR, Lee MK, Slunt HS, et al (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91: 8292-8296.
4. Bowling AC, Schulz JB, Brown RH Jr, Beal MF (1993) Superoxide dismutase activity oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61: 2322-2325.
5. Chiu AY, Zhai P, Dal Canto MC, et al (1995) Age dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 6: 349-362.
6. Dal Canto MC, Gurney ME (1994) The development of CNS pathology in a murine transgenic model of human ALS. Am J Pathol 145: 1271-1279.
7. Dal Canto MC, Gurney ME (1995) Neuropathological changes in two lines of mice carrying a transgene for mutant human CuZn SOD and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 676: 25-40.
8. Dal Canto MC, Gurney ME (1997) A low expressor line of transgenic mice carrying a mutant human CuZn superoxide dismutase (SOD1) gene develops pathological changes which most closely resemble those in human ALS. Acta Neuropathol 93: 537-550.
9. Deng H-X, Hentati A, Tainer JA, et al (1993) Amyotrophic lateral sclerosis and structural defects in CuZn superoxide dismutase. Science 261: 1047-1051.
10. Friedlander RM, Brown RH Jr, Gagliardini V, Wang J, Yuan J (1997) Inhibition of ICE slows ALS in mice. Nature 388: 31.
11. Getzoff ED, Cabelli DE, Fisher CL, et al (1992) Faster superoxide dismutase mutants designed by enhancing electrostatic guidance. Nature 358: 347-351.
12. Gurney ME, Pu H, Chiu AY, et al (1994) Motor neuron degeneration in mice that express a human CuZn superoxide dismutase mutation. Science 264: 1772-1775.
13. Gurney ME, Cutting FB, Zhai P, et al (1996) Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39: 147-157.
14. Hall ED, Andrus PK, Oostveen JA, Fleck TJ, Gurney ME (1997) Relationship of oxygen radical-induced lipid and protein oxidative damage to disease onset and progression in a transgenic model of familial ALS, unpublished data.
15. Hall ED, Oostveen JA, Gurney ME (1997) Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia, in press.
16. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251.
17. Hodgson EK, Fridovich I (1975) The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme. Biochemistry 14: 5294-5299.
18. Hottinger AF, Fine EG, Gurney ME, Zurn AD, Aebischer P (1997) The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci 9: 1548-1551.
19. Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH (1991) Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci USA 88 11158-11162.
20. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Pzedborski (1997a) Bcl-2: prolonging life in a transgenic model of familial amyotrophic lateral sclerosis. Science 277: 559-562.
21. Kostic V, Gurney ME, Deng H-X, Siddique T, Epstein CJ, Przedborski S (1997b) Midbrain dopaminergic neuronal degeneration in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 41: 497-504.
22. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Medicine 3: 614-620.
23. Kurland LT, Mulder DW (1955) Epidemiologic investigations of amyotrophic lateral sclerosis : II. Familial aggregations indicative of dominant inheritance. Neurology 5: 182-196.
24. Lacomblez L, Bensimon G, Leigh PN, et al (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347: 1425-1431.
25. Li Y, Huang TT, Carlson EJ, et al (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese Superoxide dismutase. Nature Genetics 11: 376-381.
26. Liu R, Althaus JS, Ellerbrock BR, Becker DA, Gurney ME (1997) Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis, unpublished data.
27. Lyons TJ, Liu H, Goto JJ, et al (1996) Mutations in copper-zinc Superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc Natl Acad Sci USA 93: 12240-12244.
28. Milligan CE, Prevette D, Yaginuma H, et al (1995) Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15: 385-393.
29. Mourelatos Z, Gonatas NK, Stieber A, Gurney ME, Dal Canto MC (1996) The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant CuZn Superoxide dismutase becomes fragmented in early preclinical stages of the disease. Proc Natl Acad Sci USA 93: 5472-5477.
30. Pelligrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F (1990) Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci 10: 1035-1041.
31. Przedborski S, Kostic V, Jackson-Lewis V, et al (1992) Transgenic mice with increased Cu/Zn superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 12: 1658-1667.
32. Reaume AG, Elliott JL, Hoffman EK, et al (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics 13: 43-47.
33. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92: 689-693.
34. Rosen DR, Siddique T, Patterson D, et al (1993) Mutations in CuZn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
35. Siddique T, Figlewicz DA, Pericak-Vance MA, et al (1991) Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic heterogeneity. N Engl J Med 324: 1381-1384.
36. Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VMY (1996) Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 93: 3155-3160.
37. Wiedau-Pazos M, Goto JJ, Radizadeh S, (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515-518.
38. Wong PC, Pardo CA, Borchelt DR, et al (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116.
39. Yang G, Chan PH, Chen J, et al (1994) Human copper-zinc Superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25: 165-170.
40. Yim MB, Chock PB, Stadtman ER (1990) Copperzinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide. Proc Natl Acad Sci USA 87: 5006-5010.
41. Yim MB, Chock PB, Stadtman ER (1993) Enzyme function of copper zinc superoxide dismutase as a free radical generator. J Biol Chem 268: 4099-4105.
42. m for hydrogen peroxide. Proc Natl Acad Sci USA 93: 5709-5714.